Due to the different mechanisms of HCC in various etiology of chronic liver diseases, the diagnostic performances of AFP, AFP-L3, and PIVKA-II is probably different in HCC patients with various etiology. This evidence concerns the gene AFP and hepatocellular carcinoma.